Proceeds from issuance of common stock relating to employee stock plans
Boston Scientific Proceeds from issuance of common stock relating to employee stock plans increased by 305.0% to $81M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 29.6%, from $115M to $81M. Over 4 years (FY 2021 to FY 2025), Proceeds from issuance of common stock relating to employee stock plans shows an upward trend with a 26.5% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
Higher proceeds indicate active employee participation in equity programs and provide a minor source of cash inflow.
Detailed definition
Cash inflows received from employees when they exercise stock options or purchase shares through employee stock purchase...
Peer comparison
Standard metric for companies with broad-based employee equity compensation.
financing_proceeds_from_stock_plansHistorical Data
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $20M | $64M | $8M | $52M | $6M | $59M | $19M | $63M | $27M | $75M | $17M | $80M | $26M | $96M | $28M | $115M | $32M | $115M | $20M | $81M |
| QoQ Change | — | +220.0% | -87.5% | +550.0% | -88.5% | +883.3% | -67.8% | +231.6% | -57.1% | +177.8% | -77.3% | +370.6% | -67.5% | +269.2% | -70.8% | +310.7% | -72.2% | +259.4% | -82.6% | +305.0% |
| YoY Change | — | — | — | — | -70.0% | -7.8% | +137.5% | +21.2% | +350.0% | +27.1% | -10.5% | +27.0% | -3.7% | +28.0% | +64.7% | +43.8% | +23.1% | +19.8% | -28.6% | -29.6% |
Proceeds from issuance of common stock relating to employee stock plans at Other Companies
Frequently Asked Questions
- What is Boston Scientific's proceeds from issuance of common stock relating to employee stock plans?
- Boston Scientific (BSX) reported proceeds from issuance of common stock relating to employee stock plans of $81M in Q1 2026.
- How has Boston Scientific's proceeds from issuance of common stock relating to employee stock plans changed year-over-year?
- Boston Scientific's proceeds from issuance of common stock relating to employee stock plans decreased by 29.6% year-over-year, from $115M to $81M.
- What is the long-term trend for Boston Scientific's proceeds from issuance of common stock relating to employee stock plans?
- Over 4 years (2021 to 2025), Boston Scientific's proceeds from issuance of common stock relating to employee stock plans has grown at a 26.5% compound annual growth rate (CAGR), from $110M to $282M.
- What does proceeds from issuance of common stock relating to employee stock plans mean?
- Cash received from employees exercising stock options or buying company stock.